Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ajsn6c
    Junior Member
    • Oct 2015
    • 7

    #1

    MEDIPS by Lukas Chavez in R

    I'm running a few quality controls using the most up to date MEDIPS package on my MacBook Air OS X El Capitan with 4GB of memory. I'm able to run the other quality controls: saturation analysis and sequence pattern coverage nicely. However this is the error I receive after running a CpG enrichment check. The file I ran it on is around 3GB and I only selected chr1:

    er = MEDIPS.CpGenrich(file=file,BSgenome=BSgenome, chr.select = chr.select, extend = extend,uniq = uniq)
    Reading bam alignment HCB3_45Low_merged_unique.bam
    Selecting chr1
    Total number of imported short reads: 3214352
    Extending reads...
    Creating GRange Object...
    Keep at most one 1 read mapping to the same genomic location.
    Number of remaining reads: 3211326
    Loading chromosome lengths for BSgenome.Hsapiens.UCSC.hg19...
    Calculating CpG density for given regions...

    *** caught segfault ***
    address 0x7fff4c68f380, cause 'memory not mapped'

    Traceback:
    1: .Call(.NAME, ..., PACKAGE = PACKAGE)
    2: .Call2("new_CHARACTER_from_XStringSet", x, xs_dec_lkup(x), PACKAGE = "Biostrings")
    3: .local(x, ...)
    4: as.character(ans)
    5: as.character(ans)
    6: .local(x, ...)
    7: getSeq(dataset, names = space(x), start = start(x), end = end(x), as.character = TRUE)
    8: getSeq(dataset, names = space(x), start = start(x), end = end(x), as.character = TRUE)

    I haven't found a solid answer online, but is this R's way of telling me I ran out of memory or a bug with Biostrings? I've updated Biostings prior to running this.

    Let me know what you think. Im very new to R programming, so simplifying would be appreciated.

    Thanks!

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
44 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...